Keynotes and evening events are open to Convention Access and Full Convention Access Registrations! Registration discounts end March 14, 2013 – review our packages here.
The young minds featured in the Forbes 30 Under 30 list are changing the way science, innovation and healthcare are progressing. Our luncheon promises to engage these young innovators in a forward thinking conversation examining the real future of biotechnology.
The rising stars participating include:
Laura Deming, 18, Partner, Longevity Fund
Deming has wanted to work on curing the diseases of aging for as long as she can remember. She started working in a biogerontology lab when she was 12 and matriculated at MIT when she was 14… Read more
Joshua Sommer, 24, Executive Director, The Chordoma Foundation
Sommer is executive director of the Chordoma Foundation, a nonprofit organization that proactively initiates, facilitates, and funds research to develop effective treatments, and ultimately a cure, for chordoma… Read more
Adina Mangubat, 25, Chief Executive, Spiral Genetics
Mangubat has held leadership positions in two high technology start-up companies focused in the distributed computing space. In both companies, her role included team development, executive team management… Read more
Isaac Kinde, 29, MD-PhD Candidate, Johns Hopkins School of Medicine
As an M.D. and Ph.D. candidate at Johns Hopkins, his research has focused on developing a novel DNA sequencing method to detect cancers at their earliest, most treatable stages under the expert guidance of his mentors... Read more
They reflect some of the best, new revolutionary thinking in biotechnology and healthcare and we think they’ll transform the industry with their new ideas and approaches.
Join us for what we expect will be an amazing discussion! Registration discounts end March 14, 2013 – review our packages here.